39 related articles for article (PubMed ID: 26690794)
21. Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras.
Kuhr CS; Allen MD; Junghanss C; Zaucha JM; Marsh CL; Yunusov M; Zellme E; Little MT; Torok-Storb B; Storb R
Transplantation; 2002 May; 73(9):1487-92. PubMed ID: 12023629
[TBL] [Abstract][Full Text] [Related]
22. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
Storb R; Yu C; Wagner JL; Deeg HJ; Nash RA; Kiem HP; Leisenring W; Shulman H
Blood; 1997 Apr; 89(8):3048-54. PubMed ID: 9108426
[TBL] [Abstract][Full Text] [Related]
23. Induction of immunological tolerance by porcine liver allografts.
Calne RY; Sells RA; Pena JR; Davis DR; Millard PR; Herbertson BM; Binns RM; Davies DA
Nature; 1969 Aug; 223(5205):472-6. PubMed ID: 4894426
[No Abstract] [Full Text] [Related]
24. Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation.
Locatelli F; Bauquet A; Palumbo G; Moretta F; Bertaina A
Immunol Lett; 2013; 155(1-2):21-3. PubMed ID: 24091162
[TBL] [Abstract][Full Text] [Related]
25. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
Baron D; Giral M; Brouard S
Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
[TBL] [Abstract][Full Text] [Related]
26. State of the art on the research for biomarkers allowing individual, tailor-made minimization of immunosuppression.
Sawitzki B; Reinke P; Pascher A; Volk HD
Curr Opin Organ Transplant; 2010 Dec; 15(6):691-6. PubMed ID: 20930634
[TBL] [Abstract][Full Text] [Related]
27. TCL1A, B Cell Regulation and Tolerance in Renal Transplantation.
Brinas F; Danger R; Brouard S
Cells; 2021 Jun; 10(6):. PubMed ID: 34206047
[TBL] [Abstract][Full Text] [Related]
28. Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand?
Manzia TM; Gazia C; Baiocchi L; Lenci I; Milana M; Santopaolo F; Angelico R; Tisone G
Rev Recent Clin Trials; 2019; 14(3):189-202. PubMed ID: 30868959
[TBL] [Abstract][Full Text] [Related]
29. Unexplained post-renal transplant tolerance: a case report.
Kesiraju S; Ch UM; Paritala P; Reddy S; Reddy VS; Sahariah S
Immunol Res; 2016 Jun; 64(3):791-4. PubMed ID: 26690794
[TBL] [Abstract][Full Text] [Related]
30. The Role of Natural Killer Cells in the Immune Response in Kidney Transplantation.
Pontrelli P; Rascio F; Castellano G; Grandaliano G; Gesualdo L; Stallone G
Front Immunol; 2020; 11():1454. PubMed ID: 32793200
[TBL] [Abstract][Full Text] [Related]
31. Immunobiology of transplant rejection.
Häyry P
Ann Clin Res; 1981; 13(4-5):172-98. PubMed ID: 7039479
[No Abstract] [Full Text] [Related]
32. Approaching the promise of operational tolerance in clinical transplantation.
Bishop GA; Ierino FL; Sharland AF; Hall BM; Alexander SI; Sandrin MS; Coates PT; McCaughan GW
Transplantation; 2011 May; 91(10):1065-74. PubMed ID: 21544029
[TBL] [Abstract][Full Text] [Related]
33. B cells in operational tolerance.
Chesneau M; Danger R; Soulillou JP; Brouard S
Hum Immunol; 2018 May; 79(5):373-379. PubMed ID: 29458071
[TBL] [Abstract][Full Text] [Related]
34. B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.
Pescovitz MD
Clin Transplant; 2006; 20(1):48-54. PubMed ID: 16556153
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
